Although the mechanisms by which orexin mediates its effects are still unclear, it is likely that orexin can mitigate several obesity-related dysfunctions; orexin-A, indeed, reduces weight gain in obesity-prone mice, while selective blockade of the OX1R reduces binge eating in rats [125]. Here, HCRTR1 is linked to obesity due to melanocortin 4 receptor deficiency.